Scientific Reports5: Article number: 1779210.1038/srep17792; published online: 12072015; updated: 02252016The Acknowledgements section in this Article is incomplete.“We thank Dr. Richard Schlegel for providing the 3T3-J2 cells, Dr. Kalenic and the House Research Institute for providing the HEI-OC1 cells, Dr. Guillermo Oliver for the MEFs, Dr. Suzanne Baker for the NIH 3T3 cells, and Drs. Stefan Heller and Kazuo Oshima for help on isolation of otic-spheres, and Dr. Yannan Ouyang for help on confocal microscope imaging.”should read:“We thank Dr. Richard Schlegel for providing the 3T3-J2 cells, Dr. Kalenic and the House Research Institute for providing the HEI-OC1 cells, Dr. Guillermo Oliver for the MEFs, Dr. Suzanne Baker for the NIH 3T3 cells, and Drs. Stefan Heller and Kazuo Oshima for help on isolation of otic-spheres, and Dr. Yannan Ouyang for help on confocal microscope imaging.This research was supported by funding from the National Institutes of Health grants (R01DC006471 (J.Z.), R21DC013879 (J.Z.), F32DC013832 (W.L), P30CA21765 (St. Jude)), American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children’s Research Hospital, the Office of Naval Research grants ), the Hearing Health Foundation , the National Organization for Hearing Research (NOHR) Foundation (Bradley J. W.), and The Hartwell Foundation .”


The following information is missing from the Funding section: Portuguese Foundation of Science and Technology (FCT) (PTDC/MHC-PCN/4842/2012 to SCS).


In 2013, the percentage of physicians using an EHR system was higher than the national average (78%) in seven states  (range = 87%–94%) and was lower than the national average in New Jersey (66%).Source: NCHS Research Data Center: what’s new? Winter 2014. National Electronic Health Records Survey (NEHRS). Survey data available through the NCHS Research Data Center at http://www.cdc.gov/rdc/leftbrch/whatnew.htm.Reported by: Esther Hing, MPH, ehing@cdc.gov, 301-458-4271; Chun-Ju Hsiao, PhD.


An affiliation for the first author is not indicated. Uzma Bashir Aamir is also affiliated with #2: Atta-ur-Rehman School of Applied BioSciences (ASAB), National University of Science & Technology (NUST), Islamabad, Pakistan.


Correction: Genome Med 14, 64 (2022)https://doi.org/10.1186/s13073-022-01063-5Following publication of the original article , an erroThe section currently reads:https://eveappeal.org.uk). Additional aspects of the study were supported by the Swedish Research Council Grant # 2017-00932, 2012-02961, Region Stockholm and Karolinska Institutet (ALF), Cancerfonden (Grant no. CAN 2016/696), and Radiumhem- mets Forskningsfonder  as well as by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). The work carried out by TEB was supported by MRC grant MR/P014070/1.This study was funded by the European Union’s Horizon 2020 European Research Council Programme, H2020 BRCA-ERC under Grant Agreement No. 742432 as well as the charity The Eve Appeal . Additional aspects of the study were supported by the Swedish Research Council Grant # 2017-00932, 2012-02961, Region Stockholm and Karolinska Institutet (ALF), Cancerfonden (Grant no. CAN 2016/696), and Radiumhem- mets Forskningsfonder  as well as by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). The work carried out by TEB was supported by MRC grant MR/P014070/1. Clinical trial 3 was supported by Breast Cancer Now [Grant Ref no: 2014May-CR003]”This study was funded by the European Union’s Horizon 2020 European Research Council Programme, H2020 BRCA-ERC under Grant Agreement No. 742432 as well as the charity The Eve Appeal (The original article  has been


Correction: BMC Neurol 22, 321 (2022)https://doi.org/10.1186/s12883-022-02813-zFollowing publication of the original article , the autbold.The updated Funding is provided below and the changes have been highlighted in Dominik Stelzle was supported by the German Federal Ministry of Education and Research, Grant 01KA2112B, within the Cysticercosis Network of Sub-Saharan Africa (CYSTINET-Africa). The funders had no role in the detailed study design, data collection and analysis, decision to publish, or preparation of the manuscript.Open Access funding enabled and organized by Projekt DEAL. This study was funded by the German Research Foundation (DFG) within the research grant (WI 3427/1–1) “Neurocysticercosis in sub-Saharan Africa” and by the Bill and Melinda Gates Foundation within the research grant (1017886) “Integrated Control of Cysticercosis in sub-Saharan Africa”. The original article  has been


Leukemia (2021) 36:1088–1101 10.1038/s41375-021-01475-z, published online 27 January 2022Correction to: The Acknowledgments section of this article was incomplete in the initial publication. it should read as follows:Acknowledgments: We thank Catherine A. Nicholas for her help with preliminary experiments and Morgan F. O’Keefe for manuscript proofreading. This work was supported by the National Institutes of Health Specialized Programs of Research Excellence (SPORE) grant P50100707 and P01 CA155258; as well as by the Adelson Medical Research Foundation and the Paula and Rodger Riney Foundation.


Funding statement. We failed inadvertently to acknowledge one of our funding bodies in the “Funding” section. The Funding statement read as “This work was supported by a grant from Stavros Niarchos Foundation (ST and MZ), by RSF (Grant No. 16-14-00215) (VT and II), by RFBR (Grant No. 18-04-01366) (IK) and by BioStruct-X (Contract No. 283570/3521).”In the published article, there was an error in the The correct statement is: “This work was supported by a grant from Stavros Niarchos Foundation (ST and MZ), by RSF (Grant No. 16-14-00215) (VT and II), by RFBR (Grant No. 18-04-01366) (IK), by the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (PG),  and by BioStruct-X (Contract No. 283570/3521).”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Correction: BMC Cancer 21, 409 (2021)https://doi.org/10.1186/s12885-021-08134-7Following publication of the original article , the autThis research was funded by National Science Foundation of China (81802652), Research Fund of Hubei Province Health Bureau (WJ2015MB144) and Research Fund of Wuhan Public Health Bureau (WX15A12 and WX18Y11). The funders had no role in the design of the study, data collection, analysis, interpretation of data, or in writing the manuscript.


Scientific Reportshttps://doi.org/10.1038/s41598-022-26145-7, published online 23 December 2022Correction to: The Funding section in the original version of this Article was omitted.The Funding section now reads: “This study was supported by grants  from the Chonnam National University Hospital Biomedical Research Institute to DWK, ISJ and HJC, by Chonnam National University (2021-2443 and 2022-3856-01) to DWK and HJC. This study was also supported by grants from National Research Foundation  to DWK, ISJ and HJC.”The original Article has been corrected.


Correction to: BMC Public Health 21, 1866 (2021)https://doi.org/10.1186/s12889-021-11924-0In the original publication  there waIncorrect fundingThis study was funded under the Singapore-Australia Bilateral Program on Innovations in Food for Precision Health 2019.Correct fundingThis study was funded under the Singapore-Australia Bilateral Program on Innovations in Food for Precision Health 2019. BPC Smith was supported by a National Research Foundation Singapore Whitespace grant (grant no. W20W3D0002) and Health and Biomedical Sciences Industry Alignment Fund Pre-positioning grant (H1801a0–014) administered by the Agency for Science, Technology & Research.


Scientific Reports 10.1038/s41598-022-21836-7, published online 09 November 2022Correction to: The Funding section in the original version of this Article was omitted. The Funding section now reads:“This research was supported by the Kasetsart University Research and Development Institute, KURDI (R-M 52.63), Bangkok, and the Health Systems Research Institute (HSI), Thailand.”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-22159-3, published online 03 November 2022Correction to: The Funding section in the original version of this Article was incomplete."This work was supported by the National Science Centre [grant number 2016/21/D/NZ8/01306 (IN)]; the Ministry of Science and Higher Education [grant number IdP2011000161 (GJ)]; and the Ella & Georg Ehrnrooth Foundation (MB)."now reads:“This work was supported by the National Science Centre [grant number 2016/21/D/NZ8/01306 (IN)]; the Ministry of Science and Higher Education [grant number IdP2011000161 (GJ)]; and the Ella & Georg Ehrnrooth Foundation (MB). Publication of this article was funded by the Priority Research Area qLife under the program “Excellence Initiative – Research University” at the Jagiellonian University in Krakow (06/IDUB/2019/94).”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-16028-2, published online 16 July 2022Correction to: The Acknowledgments section in the original version of this Article was incomplete.“This work was supported by Medical Scientist Training Program T32GM008152, National Institutes of Health grants U54CA193419, R01 CA228272, R01CA225002, and National Science Foundation grants EFMA-1830961 and EFMA-1830969. This work made use of the BioCryo facility of Northwestern University’s NUANCE Center, which has received support from the SHyNE Resource (NSF ECCS-2025633), the International Institute for Nanotechnology (IIN), and Northwestern's MRSEC program (NSF DMR-1720139). The imaging methodology is partially based on research sponsored by the Air Force Research laboratory under agreement number FA8650-15-2-5518. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of Air Force Research Laboratory or the U.S. Government.”now reads:“This work was supported by Medical Scientist Training Program T32GM008152, National Institutes of Health grants U54CA268084, U54CA261694, R01CA228272, R01CA225002, and National Science Foundation grants EFMA-1830961 and EFMA-1830969. This work made use of the BioCryo facility of Northwestern University’s NUANCE Center, which has received support from the SHyNE Resource (NSF ECCS-2025633), the International Institute for Nanotechnology (IIN), and Northwestern's MRSEC program (NSF DMR-1720139). The imaging methodology is partially based on research sponsored by the Air Force Research laboratory under agreement number FA8650-15-2-5518. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of Air Force Research Laboratory or the U.S. Government.”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-09323-5, published online 31 March 2022Correction to: The original version of this Article contained errors.Shahzaib Ashraf was incorrectly affiliated with ‘Department of Mathematics and Statistics, Bacha Khan University, Charsadda, KPK, Pakistan’. The correct affiliation is listed below.Department of Mathematics, Khawaja Farid University of Engineering and Information Technology, Rahim Yar Khan, PakistanIn the Acknowledgements section,“Muhammad Naeem would like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant Code: (22UQU4310396DSR02).”now reads:“Muhammad Naeem would like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant Code: (22UQU4310396DSR06).”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-13132-1, published online 03 June 2022Correction to: The Funding section in the original version of this Article was incomplete.“Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology 19K09003.”now reads:“This study was funded by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology 19K09003 and Medtronic".The original Article has been corrected.


In the article titled Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds, the funding acknowledgment was partially incorrect as published.Original versionAcknowledgmentsThis research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2021R111A1A01048981) and the Korea government  (NRF-2017R1C1B5077043).Corrected versionAcknowledgmentsThis research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2021R111A1A01048981) and the National Research Foundation (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1C1C1014148).


DOI: 10.1039/C9RA08707ACorrection for ‘Boron-doped few-layer graphene nanosheet gas sensor for enhanced ammonia sensing at room temperature’ by Shubhda Srivastava  The authors regret that affiliation b was incorrectly provided as Academy of Scientific and Innovative Research (AcSIR), CSIR-National Physical Laboratory Campus, Dr K S Krishnan Road, New Delhi 110012, India.The correct details are provided in the Affiliations section of this document.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Correction to: BMC Health Serv Res 22, 568 (2022)https://doi.org/10.1186/s12913-022-07922-6Following publication of the original article , the autH21C0059).The statement in the ‘Funding’ section originally read: This research was supported by a grant of Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health & Welfare, Republic of Korea .The statement in the ‘Funding’ section should read: This research was supported by a grant of Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI19C0481, The original article  has been


Scientific Reports 10.1038/s41598-020-69403-2, published online 23 July 2020Correction to: The original version of this Article contained an error in Affiliation 2, which was incorrectly given as ‘Academy of Scientific and Innovative Research (AcSIR), New Delhi 110025, India’. The correct affiliation is listed below:Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, IndiaThe original Article has been corrected.


Scientific Reportshttps://doi.org/10.1038/s41598-022-24021-y, published online 02 December 2022Correction to: The original version of this Article contained an error in the spelling of the author Rizwan Ali which was incorrectly given as Ali Rizwan.In addition, Rizwan Ali was incorrectly affiliated with ‘Light and Electron Microscopy Unit, Medical Core Facility and Research Platforms, King Abdullah International Medical Research Centre, National Guard Health Affairs, Mail Code 1515, P.O. Box 3660, Riyadh 11481, Saudi Arabia’. The correct affiliation is listed below.King Abdullah International Medical Research Center (KAIMRC), Medical Research Core Facility and Platforms (MRCFP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia.The original Article has been corrected.


Correction to: BMC Public Health 22, 760 (2022)https://doi.org/10.1186/s12889-022-13152-6In the original publication  there waIncorrect fundingThis research does not receive any funding.Correct fundingThis work was funded by the National Natural Science Foundation of China  and the National Key Research and Development Program of China (Grant No. 2018YFC1315302).


Nature Communications 10.1038/s41467-022-34062-6, published online 25 October 2022Correction to: In this article the affiliation ‘Institute of Materials Research and Engineering, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore’ for Jie Yin was missing. The original article has been corrected.


Scientific Reports 10.1038/s41598-022-25027-2, published online 01 December 2022Correction to: The original version of this Article contained an error in the Acknowledgements section.“This work was partially funded by the Project TAMI—Transparent Artificial Medical Intelligence (NORTE-01-0247-FEDER-045905) financed by ERDF—European Regional Fund through the North Portugal Regional Operational Program—NORTE 2020 and by the Portuguese Foundation for Science and Technology—FCT under the CMU—Portugal International Partnership, and also by the Portuguese Foundation for Science and Technology—FCT within PhD grants SFRH/BD/139468/2018 and 2020.06434.BD. The authors thank the Swiss National Science Foundation grant number 198388, as well as the Lindenhof foundation for their grant support.”now reads:“This work was supported by National Funds through the Portuguese Funding Agency, FCT–Foundation for Science and Technology Portugal, under Project LA/P/0063/2020, and also by the Portuguese Foundation for Science and Technology - FCT within PhD grants SFRH/BD/139468/2018 and 2020.06434.BD. The authors thank the Swiss National Science Foundation grant number 198388, as well as the Lindenhof foundation for their grant support.”The original Article has been corrected.


Correction: Trials 23, 459 (2022)https://doi.org/10.1186/s13063-022-06377-8Following publication of the original article , the aut1 Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, ChinaThe affiliation of Jing Zhao was incorrect upon publication. Jing Zhao is affiliated to Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, China.Further to this, the funding section has been updated as follows:This project is funded by Shanghai '13th five-year plan' key clinical specialty (TCM gynecology department) (shslczdzk04501) and General program of clinical research of Shanghai Municipal Health Commission (202140173).The original article  has been


Cellular & Molecular Immunology 10.1038/s41423-022-00928-4, published online 27 October 2022Correction to: In this article the statement in the Acknowledgements section was incorrectly given as “MRB and IIS are supported by the NIH R01GM080139 grant (to IIS), the Welch Foundation Research Grant AU-2014-20190331 (to IIS), and the American Heart Association grant 18CDA34110086 (to MRB)” and should have been, “MRB and IIS are supported by the NIH R01GM072804 grant (to IIS), the Welch Foundation Research Grant AU-2014-20190331 (to IIS), and the American Heart Association grant 18CDA34110086 (to MRB).”The original article has been corrected.


Correction: Ann Clin Microbiol Antimicrob (2023) 22:5 https://doi.org/10.1186/s12941-023-00553-7Following publication of the original article , the autFundingThis work was supported by the National Natural Science Foundation of China , the Natural Science Foundation of Jiangsu Province (Grant No. BK20201129), the Wuxi City Health Committee top-notch talent (Grant No. BJ2020077).The original article has been corrected.


The funding statement for this article should read as follows:https://ec.europa.eu/research/mariecurieactions/), grant number 750835. GP received support from the Austrian Science Fund (FWF) (https://fwf.ac.at/en/); grant number PI2760-B30. PL holds a Wellcome Trust Senior Research Fellowship (209450/Z/17/Z) and is supported by BHF [PG/16/75/32383]. SAN is supported by NIH R01-HL152256, ERC PREDICT-HF 453 (864055), BHF (RG/20/4/34803), EPSRC (EP/P01268X/1). This work was supported by the Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]. This work made use of ARCHER (http://www.archer.ac.uk/), the UK national high-performance computing service located at the University of Edinburgh and funded by the Office of Science and Technology through Engineering and Physical Sciences Research Councils High-End Computing Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”“CR and MM have received funding from the European Union’s Horizon 2020 Research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No 764738. MS was supported by an unrestricted Abbott educational grant through the Centre for Doctoral Training in Medical Imaging at King’s College London. CA received support from the Marie Sklodowska-Curie fellowship (


Volume 6 of Learning Health Systems. An open access publication, the journal has advanced research and scholarship on learning health systems in partnership with our reviewers. With indexing in multiple major sources and the recent news that we will have an official impact factor next year, we believe the journal is now on a sustainable, positive trajectory.The publication of Issue 4 marks the completion of We were also delighted to learn that articles from the journal were downloaded over 100 000 times in 2021.Special Issues: “Patient Empowerment and the Learning Health System” (v.1); “Ethical, Legal, and Social Implications of Learning Health Systems” (v.2); “Learning Health Systems: Connecting Research to Practice Worldwide” (v.3); “Human Phenomics and the Learning Health System” (v.4); “Collaborative Learning Health Systems: Science and Practice” (v.5); and “Education To Meet the Multidisciplinary Workforce Needs of Learning Health Systems” (v.6). Our talented guest editors have been instrumental in helping these Special Issues come to fruition.The journal has also published six We are keenly aware that these achievements would not have happened without the dedicated efforts and insightful comments of all those individuals who accepted invitations to review submitted articles. With busy schedules and full commitments in the midst of the Covid‐19 pandemic, these individuals found the time and energy to contribute their expertise to our authors to help ensure that their papers met (and often exceeded) the journal's high standards for publication.Please accept our sincere gratitude for your outstanding efforts.Charles P. Friedman, Editor in ChiefREVIEWERS FOR VOLUME 6 LHS JOURNALIncludes reviewers of rejected manuscriptsJulia Adler‐Milstein (United States)Joan Ash (United States)Mark Ashworth (United Kingdom of Great Britain and Northern Ireland)Ross Bailie Eta Berner (United States)Jeff Brown (United States)Michael Cantor (United States)Jim Cimino (United States)Derek Corrigan (Ireland)Vasa Curcin (United Kingdom of Great Britain and Northern Ireland)Brendan Delaney (United Kingdom of Great Britain and Northern Ireland)Catherine Diederich (United States)Deborah Dinardo (United States)Gerry Douglas (United States)Archie Drake (United Kingdom of Great Britain and Northern Ireland)Christine Dymek (United States)Margo Edmunds (United States)Jordan Everson (United States)Stephan Fihn (United States)Erin P. Finley (United States)Allen Flynn (United States)Thomas Foley (United Kingdom of Great Britain and Northern Ireland)Emily Ginier (United States)Shaun Grannis (United States)Sarah Greene (United States)Jeanne‐Marie Guise (United States)W. Ed Hammond (United States)Kristi Holmes (United States)Kelli Johnson (United States)Owen Johnson (United Kingdom of Great Britain and Northern Ireland)Dipak Kalra (Belgium)Amy Kilbourne (United States)Rebecca Kush (United States)Elyse Lasser (United States)Harold Lehmann (United States)Christopher Longhurst (United States)Nancy Lorenzi (United States)David McCallie (United States)Mark McGilchrist (United Kingdom of Great Britain and Northern Ireland)Marianne McPherson (United States)Brad Malin (United States)Kenneth Mandl (United States)Erik Mayer (United Kingdom of Great Britain and Northern Ireland)Daniella Meeker (United States)Paul Meissner (United States)Michelle Mengeling (United States)Blackford Middleton (United States)Tara Montgomery (United States)David Mosen (United States)Cheryl Moyer (United States)Mark Musen (United States)Paige Nong (United States)Sally Okun (United States)Nancy Pandhi (United States)Gareth Parry (United States)Niels Peek (United Kingdom of Great Britain and Northern Ireland)Jodyn Platt (United States)Rachel Richesson (United States)Jamie Roberts (United States)Joshua Rubin (United States)Philip Scott (United Kingdom of Great Britain and Northern Ireland)Ruth Simmons (United States)Karandeep Singh (United States)Carolynn Smith Jean Soler Caren Stalberg (United States)Zachary Strasser (United States)Ndidi Unaka (United States)Kim Unerti (United States)Barbara Van de Castle (United States)Robert Verheij (Netherlands)Sam Volchenboum (United States)Jim Walker (United States)Denise Warzel (United States)Terrie Wheeler (United States)Paul Wicks (United States)


The funding statement for this article should read as follows:“J.L., H.Y. and D.R-G. acknowledge partial funding from the National Science Foundation- Division of Mathematical Sciences (NSF-DMS) grants DMS-1953410, DMS-1714973 and DMS-1763272/Simons Foundation  for the Center for Multiscale Cell Fate Research at UC Irvine. M.W acknowledge partial funding from NSF-DMS-2012330. JL additionally acknowledges partial funding from the National Institutes of Health (NIH) grant 1U54CA217378- 01A1 for a National Center in Cancer Systems Biology at the UC Irvine , and from NIH grant P30CA062203 for the Chao Family Comprehensive Cancer Center at UC Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”


Scientific Reports 10.1038/s41598-022-26284-x, published online 16 December 2022Correction to: The Acknowledgements section in the original version of this Article was omitted. The Acknowledgements section now reads:“This work was supported by the Interdisciplinary Research Center for Renewable Energy and Power Systems at King Fahd University of Petroleum & Minerals (KFUPM) under Project INRE2221.”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-17759-y, published online 05 September 2022Correction to: The original version of this Article contained an error in the Acknowledgments section.“This work was supported by the National Natural Science Foundation of China (Grant Nos. 11975176), the Natural Science Basic Research Plan in Shaanxi Province of China (Grant No. 2019JM-139), the Key Research and Development Program of Shaanxi Province (No. 2020KW-011), the Fundamental Research Funds of Shaanxi Key Laboratory of Artificially-Structured Functional Materials and Devices (No. AFMD-KFJJ-21207).”now reads:“This work was supported by the National Natural Science Foundation of China (Grant No. 11975176), the Key Research and Development Program of Shaanxi Province (No. 2020KW-011), the Fundamental Research Funds of Shaanxi Key Laboratory of Artificially-Structured Functional Materials and Devices (No. AFMD-KFJJ-21207) and Natural Science Foundation of Shaanxi (2022JQ-660).”The original Article has been corrected.


Scientific Reportshttps://doi.org/10.1038/s41598-022-20995-x, published online 06 October 2022Correction to: The Acknowledgements section in the original version of this Article was incomplete.“This research was supported by the Kumoh National Institute of Technology (2019-104-044) and the Hustar Medical Industry Innovation University Project and Nano-Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF2021M3H4A407927511 and 2021M3H4A4079264).”now reads:“This research was supported by the Kumoh National Institute of Technology (2019-104-044) and the Hustar Medical Industry Innovation University Project, S3310771  and Nano-Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF2021M3H4A407927511 and 2021M3H4A4079264) and Nanomedical Devices Development Project of NNFC in 2022."The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-13662-8, published online 10 June 2022Correction to: The Funding section in the original version of this Article was incomplete."NHMRC  project grant (application ID 1063608). This project received seed funding from a Pfizer Neuroscience Research Grant (2011) (application ID WS1931543). Chris Moran was supported by a NHMRC-ARC  Dementia Research Fellowship (application ID 1109482)."now reads:“NHMRC  project grant (application ID 1063608). This project received seed funding from a Pfizer Neuroscience Research Grant (2011) (application ID WS1931543). Chris Moran was supported by a NHMRC-ARC  Dementia Research Fellowship (application ID 1109482). The Australian Twin Registry  receives support from the National Health and Medical Research Council through a Centre of Research Excellence Grant, which is administered by the University of Melbourne.”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-14259-x, published online 16 June 2022Correction to: The original version of this Article contained an error in the Acknowledgments section."The authors would like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant Code: 22UQU4331317DSR14. The authors acknowledge the financial support provided by the Center of Excellence in Theoretical and Computational Science (TaCS-CoE), KMUTT. Kamel SMIDA would like to express his gratitude to AlMaarefa University, Riyadh, Saudi Arabia, for providing funding (TUMA-2021-17) to do this research. Moreover, this research project is supported by Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2022 under project number FRB650048/0164."now reads:"The authors would like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant Code: 22UQU4331317DSR16. The authors acknowledge the financial support provided by the Center of Excellence in Theoretical and Computational Science (TaCS-CoE), KMUTT. Kamel SMIDA would like to express his gratitude to AlMaarefa University, Riyadh, Saudi Arabia, for providing funding (TUMA-2021-17) to do this research. Moreover, this research project is supported by Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2022 under project number FRB650048/0164."The original Article has been corrected.


Functional mobility training with a powered knee and ankle prosthesis by Finucane SB, Hargrove LJ and Simon AM (2022). Front. Rehabilit. Sci. 3:790538. doi: 10.3389/fresc.2022.790538A corrigendum on Incorrect FundingIn the published article, there was an error in the Funding statement. The funding statement was missing an additional funding source as listed below. Original text: Funding for this report was provided by the US Army's Telemedicine and Advanced Technology Research Center (TATRC) contract WW81XWH-09-2-0020, the US Army's Joint Warfighter Program contract W81XWH-14-C-0105, and the National Institute of Health NIH R01 HD079428-02.The correct Funding statement appears below.FundingFunding for this report was provided by the US Army's Telemedicine and Advanced Technology Research Center (TATRC) contract WW81XWH-09-2-0020, the US Army's Joint Warfighter Program contract W81XWH-14-C-0105, the National Institute of Health (NIH) R01 HD079428-02 and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90REGE0003. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Correction: Respiratory Research (2022) 23:309 https://doi.org/10.1186/s12931-022-02113-7Following publication of the original article , the autIt has been updated in this correction.The updated Funding section should read as below:FundingThis study was supported by the National Natural Science Foundation of China (61976238); Shanghai Municipal Science and Technology Commission (21Y11910500); Shanghai Municipal Health Commission (20204Y0299); Medical Imaging Key Program of Wise Information Technology of 120, Health Commission of Shanghai 2018ZHYL0103 (ML), “Future Star” of famous doctors’ training plan of Fudan University. This study was also supported by the Shanghai Municipal Science and Technology Commission (20Y11902900).The original article has been corrected.


T. N. Nha et al., RSC Adv., 2021, 11, 30054–30068. DOI: 10.1039/D1RA03216JCorrection for ‘Sensitive MnFe The authors regret that an incorrect grant number was shown in the acknowledgements section of the published article. The corrected section should read:This work was supported by the Vietnam Academy of Science and Technology (VAST) by Program of Development in the field of Physics by 2020 under grant number KHCBVL.02/20-21, and partly by AOARD Award No. FA2386-17-1-4042.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Correction: BMC Health Services Research 22, 1591 (2022)https://doi.org/10.1186/s12913-022-08991-3Following publication of the original article , the autThe incorrect author name is: John D. PowersThe correct author name is: John H. PowersIn addition, the authors identified an error in the affiliation of John H. Powers (affiliation 4): it was corrected from ‘Clinical Research Directorate, Frederick National Laboratory for Cancer Research’ to ‘George Washington University School of Medicine’.The author group and list of affiliations has been updated above and the original article  has been


Scientific Reports 10.1038/s41598-022-22644-9, published online 28 October 2022Correction to: The Funding section in the original version of this Article was omitted. The Funding section now reads:“We would like to thank the School of Information Technology and Engineering, Vellore Institute of Technology, Vellore, India − 632014 for paying APC for this study.”The original Article has been corrected.


Correction to: Journal of Immigrant and Minority Health10.1007/s10903-022-01402-zThe original version of this article unfortunately missed to include Acknowledgement section.Therefore, the complete section is given here:Acknowledgements: This work was supported by Promoting Grants for Research Toward Resilient Society 2021 (Tohoku University) and Ensemble Grants for Early Career Researchers 2021 (Tohoku University).The original article has been corrected.


Correction to: BMC Medical Imaging (2022) 22:153https://doi.org/10.1186/s12880-022-00874-7Following the publication of the original article , we wereThe statement "This study was supported by the National Natural Science Foundation of China [81771834] and the Natural Science Foundation of Beijing [Z181100001718017]" should be replaced by "None".The original article has been revised as above.


BioMed Research International has retracted the article titled “Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis” [Following an investigation conducted by the Hindawi Research Integrity team , signifiThe authors do not agree to the retraction.


Correction: Biotechnol Biofuels (2020) 13:73 10.1186/s13068-020-01714-yFollowing publication of the original article , the autFundingThis work is partially supported by grants from National Key R&D Program of China (2018YFA0902500), National Youth Thousand Talents Program of China and Peking University CCUS project supported by BHP Billiton.The original article  has been


Jung, E. S., Suh, K., Han, J., Kim, H., Kang, H.‐S., Choi, W.‐S., & Mook‐Jung, I. (2022).Aging Cell, 21, e13623. https://doi.org/10.1111/acel.13623In Jung et al. (2022), the authors would like to correct the grant numbers listed under funding information section. The revised funding information should read as follows:Funding informationHU20C0187 and HU20C0198).This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) and Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (grant numbers The authors would like to apologize for the inconvenience caused.


Correction: BMC Health Serv Res 22, 586 (2022)https://doi.org/10.1186/s12913-022-07936-0Following publication of the original article , the autThe sentence originally read:years  and 49 years  respectively and they ranged between 13 and 50 months for PD and one and 21 years for HD.The median dialysis vintage of PD and HD patients were 36 The sentence should read:months  and 49 months  respectively and they ranged between 13 and 50 months for PD and one and 21 years for HD.The median dialysis vintage of PD and HD patients were 36 The original article  has been


Signal Transduction and Targeted Therapy 10.1038/s41392-022-00970-8, published online 27 May 2022Correction to: In this article, the funding from “National Natural Science Foundation of China to YR (Grant# 82125034), National Key R&D Program of China .” was omitted.The original article has been corrected.


Page 1: The title should appear as given in this Erratum.Volume 9, no. 3, 2021, Page 12, Acknowledgments: The first paragraph should read as follows. “This work was supported by the Natural Science Foundation of Guangdong Province, China (2022A1515011532), Foundation for Innovative Research Groups of the National Natural Science Foundation of China (32121004), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2019BT02N054), and Innovation Team Project of Guangdong University (2019KCXTD001).”


Scientific Reportshttps://doi.org/10.1038/s41598-022-16984-9, published online 27 July 2022Correction to: The original version of this Article contained an error in the Methods section.In the Methods section, under the subheading ‘Study design’,“This study was approved by the Research Ethics Committee Office of National Taiwan University Hospital (No. 201803013RINA).”now reads:“This study was approved by the Research Ethics Committee Office of National Taiwan University Hospital (No. 201803013RINA) and the Institutional Review Board (IRB) of Chang Gung Memorial Hospital (IRB No. 201800767B0C501).”The original Article has been corrected.


Scientific Reports 10.1038/s41598-022-20348-8, published online 06 October 2022Correction to: The original version of this Article contained an error in the Author Information section.“These authors contributed equally: Hae-Yeon Park, DoGyeom Park, Seungchul Lee and Sun Im.”now reads:“These authors contributed equally: Hae-Yeon Park and DoGyeom Park.These authors jointly supervised this work: Seungchul Lee and Sun Im.”In addition, the Article contained an error in the Funding section.“This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (no. 2020R1F1A106581412), the by the Po-Ca Networking Groups funded by The Postech-Catholic Biomedical Engineering Institute (No. 5-2020-B0001-00050) and by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A6A1A03047902).”now reads:“This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (no. 2020R1F1A106581413), by the Po-Ca Networking Groups funded by The Postech-Catholic Biomedical Engineering Institute (No. 5-2020-B0001-00050) and by the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A6A1A03047902).”The original Article and accompanying Supplementary Information file have been corrected.


Scientific Reportshttps://doi.org/10.1038/s41598-021-93742-3, published online 12 July 2021Correction to: The original version of this Article contained an error in the Funding section.https://www.jpnd.eu  and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London.”“This work was funded by the Motor Neurone Disease Association (Grant: Jones/Oct15/958-799) and the ALS Association (Grant: 18-LGCA- 394 "HERV-K molecular studies in ALS"). AAC is an NIHR Senior Investigator. This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - now reads:https://www.jpnd.eu  and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London.”“This work was funded by the Motor Neurone Disease Association (Grant: Jones/Oct15/958-799), the ALS Association (Grant: 18-LGCA- 394 "HERV-K molecular studies in ALS") and MND Scotland . AAC is an NIHR Senior Investigator. This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - The original Article has been corrected.


Scientific Reportshttps://doi.org/10.1038/s41598-023-28294-9, published online 21 January 2023Correction to: The original version of this Article contained an error in the Funding section.“This study was supported by a grant from Shaanxi Provincial Key Research and Development Project (CN) (grant no. 2021SF-224) and Xi’an Health Scientific Research Talent Project (CN) (grant no. J202102038). The authors have no conflicts of interest to declare.”now reads:“This study was supported by a grant from the Clinical Medical Research Center Projects - Innovation Capability Support Program of Shaanxi Province (2020LCZX-030). The authors have no conflicts of interest to declare.”The original Article has been corrected.


Funding statement. “This work was supported by National Key Programs of China during the 13th Five-Year Plan Period (2018ZX09711001-002-012) and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZY2017202).” The correct Funding statement appears below.In the published article, there was an error in the Funding“This work was supported by National Key Programs of China during the 13th Five-Year Plan Period (2018ZX09711001-002-012) and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYGD20001).”The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


After publication of this article , the autM. Saruta has received consulting and lecture fees from Abbvie GK., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd, EA Pharma Co., Ltd., and Gilead K.K; and research grants from EA Pharma Co., Ltd., EP-CRSU Co., Ltd., Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co., Ltd.The other authors have no conflicts of interest related to this article.The original article  has been


Prisons are high-risk environments for the transmission of drug related infections, due to over-incarceration of people who inject drugs; often inadequate healthcare, substandard prison conditions; and others. An overview of the availability and coverage of prison-based harm reduction interventions in Europe is presented.National Focal Points of the EMCDDA (30) collected 2019 data, which were integrated with findings from the European funded project HA-REACT (Joint Action on HIV and Co-infection Prevention and Harm Reduction).Prison based harm reduction interventions are available in European countries, but only few of them are available in most countries and often with a low coverage (e.g. less than 10% of prison population in Opioid Substitution Treatment (OST) in most countries). Interventions available in most countries (20 or more) include: HIV, HBV, HCV testing (29), OST continued from community (29), Referral to HIV treatment upon release (28), HIV treatment (27), Referral to HCV treatment upon release (25), HCV antiviral treatment (25), Testing for TB (23), HBV antiviral therapy (25), OST initiated in prison (22), Treatment for TB (21), Vaccination for HBV (20). Interventions available in 10 to 19 countries are: condom distribution (19), OST (re)initiated before release (17), prison/community guidelines for implementation of OST (13). Interventions provided in < 10 countries include: distribution of disinfectant (9), condom with lubricant (9), take-home naloxone (5), needles and syringes programs (3).Compared to the community, the availability and coverage of harm reduction interventions in European prisons are limited and large information gaps exist. Scaling up harm reduction in prison can achieve important individual and public-health benefits.


Correction to: Trials 23, 162 (2022)https://doi.org/10.1186/s13063-022-06083-5Following the publication of the original article , we wereOriginally published sections:Funding: “The Wushu Research Institute of the State Sports General Administration (WSH2018A005).Authors’ contributions: “LYK was involved in the conception and design of the research. LYH obtained ethics approval. LYH drafted the manuscript. All authors edited and revised the manuscript. All authors approved the final version of the manuscript.”Corrected sections:Funding: “Fund Project: Zhejiang Provincial Department of Education College Teacher Professional Development Project (FX2018064); Zhejiang Provincial Department of Education University Scientific Research Program Project (Y201533645)”Authors’ contributions: “LXW was involved in the conception and design of the research. LXW obtained ethics approval. LYH drafted the manuscript. All authors edited and revised the manuscript. All authors approved the final version of the manuscript.”The original article has been corrected.


Scientific Reports 10.1038/s41598-022-25099-0, published online 01 December 2022Correction to: The original version of this Article contained an error in the Funding section.“This study was supported by the Polish National Science Center, grant number: 2016/23/B/HS6/03843. N.K-G was supported by the Foundation of Polish Science (FNP) and the Kosciuszko Foundation.”now reads:“This study was supported by the Polish National Science Center, grant number: 2016/23/B/HS6/03843. N.K-G was supported by the Foundation of Polish Science (FNP) and the Kosciuszko Foundation. Open access was funded by SWPS University Research Development.”The original Article has been corrected.


Humanities and Social Sciences Communications 10.1057/s41599-022-01338-7, published online 26 September 2022.Correction to: In this article the funding from the French government under the “France 2030” investment plan managed by the French National Research Agency (reference: ANR-17-EURE-0020) and from Excellence Initiative of Aix-Marseille University - A*MIDEX.” and Federal funds from the National Institutes of Health, Department of Health and Human Services, under Contract No. 75N91020C00039 was omitted. The original article has been corrected.


Scientific Reports 10.1038/s41598-022-07773-5, published online 08 March 2022Correction to: The original version of this Article omitted an affiliation for Yoon‑Sang Oh and Sang‑Won Yoo. Their correct affiliation is listed below:Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaThe original Article has been corrected.


The authors regret that the funding information was not included in the acknowledgements in the original article. The following acknowledgements should have been included:This work was supported in part by the Engineering and Physical Science Research Council (EPSRC) through Engineering Fellowship for Growth—PRINTSKIN (EP/M002527/1) and neuPRINTSKIN (EP/R029644/1) and EPSRC ORCA – Partnership Resource Fund Project MUSES (EP/R026173/1). In addition, this work received support from the European Union’s Horizon 2020 Research and Innovation Programme (AQUASENSE Project) under the Marie Skłodowska-Curie grant agreement No: H2020-MSCA-ITN-2018-813680.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Nature Communications 10.1038/s41467-022-30236-4, published online 19 May 2022.Correction to: The original version of this Article contained an error in Acknowledgements, which incorrectly read ‘We thank Edward Owusu-Ansah, Alex Whitworth, Ronald Davis, and the Bloomington Drosophila Stock Center at Indiana University (supported by NIH P40OD018537) for fly stocks, Michael Ryan for the NDUFB10KO, NDUFS4KO, and control cell lines, David Clapham for other HEK293T cell lines, John Elrod, Ronald Kahn, and Nils-Göran Larsson for mouse lines, James Marvin and Flow Cytometry Core staff at the University of Utah (supported by NIH P30CA042014), Small Animal Ultrasound Core staff at the University of Utah, and Derek Warner and DNA Sequencing Core staff at the University of Utah.’ The correct version states ‘We thank Edward Owusu-Ansah, Alex Whitworth, Ronald Davis, and the Bloomington Drosophila Stock Center at Indiana University (supported by NIH P40OD018537) for fly stocks, Vamsi Mootha for multiple plasmids and MCU knockout cell lines, Michael Ryan for the NDUFB10KO, NDUFS4KO, and control cell lines, David Clapham for other HEK293T cell lines, John Elrod, Ronald Kahn, and Nils-Göran Larsson for mouse lines, James Marvin and Flow Cytometry Core staff at the University of Utah (supported by NIH P30CA042014), Small Animal Ultrasound Core staff at the University of Utah, and Derek Warner and DNA Sequencing Core staff at the University of Utah’. This has been corrected in both the PDF and HTML versions of the Article.


Scientific Reports 10.1038/s41598-021-85630-7, published online 24 March 2021Correction to: The Acknowledgements section in this Article is incorrect.“This study was supported by 2021 the RDA Fellowship Program of National Institute of Animal Science, Rural Development Administration, Republic of Korea.”should read:“This research was funded by Rural Development Administration, Korea (grant number: PJ0147962021).”


Pseudomonas aeruginosa has become one of the most common pathogens associated with nosocomial infections. A series of susceptibility studies was designed to evaluate the activity of tebipenem against a panel of P. aeruginosa isolates known to have alterations in efflux pumps, outer-membrane porins, and expression of AmpC beta-lactamase enzymes compared to a subset of wild-type organisms.SPR994 is an orally bioavailable pivoxil hydrobromide prodrug of tebipenem, a novel oral carbapenem with activity against Gram-positive and -negative bacteria currently under development for the treatment of urinary tract infections (UTI). P. aeruginosa isolates was subjected to tebipenem and five other challenge compounds  in order to determine minimum inhibitory concentration (MIC) values, in triplicate, using standard agar dilution methodologies. P. aeruginosa ATCC 27853 was used as an internal control and all reported MIC values represented the modal value.A panel of 20 Table 1) and were similar to those found for meropenem and ertapenem with MIC values ranging from ≤0.03 to 16 mg/L and ≤0.25 to 128 mg/L, respectively. The deletion of MexB decreased the carbapenem MIC values by 2 to 4x while deletion of MexCD-OprJ and MexXy did not. Simultaneous deficiencies in MexAB, CD, EF, and XY did not decrease MIC values in comparison with the deletion of MexAB alone. Isolates possessing a derepressed AmpC showed no significant elevation in MIC value compared to wild-type isolates while those known to have lost OprD resulted in carbapenem MIC values increasing by ~4 to 32x. The combined loss of OprD and overexpression of AmpC resulted in the highest carbapenem MIC values (≥16 mg/L). Levofloxacin, tetracycline, and carbenicillin MIC values ranged from ≤0.06 to 16 mg/L, 0.5 to 64 mg/L, and ≤0.125 to >128 mg/L, respectively. All MIC values determined for the internal control were within Clinical Laboratory Standard Institute reported values.Tebipenem MIC values ranged from 0.25 to >64 mg/L for the 20 isolates evaluated Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC (Grant/Research Support)Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Grant/Research Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC (Grant/Research Support)Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support) Haley Conde, B.S., 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC (Grant/Research Support)Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Grant/Research Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC (Grant/Research Support)Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support) Nicole Cotroneo, Spero Therapeutics  Ian A. Critchley, Ph.D., Spero Therapeutics  Thomas R. Parr, Ph.D., Spero Therapeutics  Paul G. Ambrose, Pharm.D., FIDSA, 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Research Grant or Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support)


Enterobacterales (CREs). Carbapenemase-negative (CN) CRE isolates have been reported, but the activity of newer agents against these isolates is still not well understood. We evaluated the activity of MVB against CN-CRE collected during 6 years of surveillance in US hospitals.Meropenem-vaborbactam (MVB) is an important addition to the armamentarium to treat infections caused by carbapenem-resistant Enterobacterales isolates collected in US hospitals from 2014-2019 were susceptibility tested by reference broth microdilution methods. Results were interpreted using CLSI 2020 breakpoints. CRE isolates were submitted to PCR/sequencing (2014-2015) or whole genome sequencing  for characterization of carbapenemase genes. Isolates from 2016-2019 were evaluated for other beta-lactam resistance mechanisms.A total of 27,968 K. pneumoniae (16 isolates) followed by E. cloacae (9), E. coli (8), and K. aerogenes (8). MVB was the most active agent tested against these isolates, inhibiting 47/48 (97.9%) of the isolates tested. The only isolate displaying a resistant MIC for MVB was a P. mirabilis  collected in 2015. Meropenem alone inhibited only 2.1% of the isolates. Other beta-lactams inhibited 4.2 to 14.6% of the isolates. Among non-beta-lactam comparator agents, tigecycline and amikacin inhibited 93.8 and 91.7% of the isolates, respectively, when applying CLSI or US FDA breakpoints. A total of 89.6% of the isolates had intermediate colistin MIC values. Among the 27 isolates collected from 2016-2019 that were submitted to WGS, 15 harbored CTX-M encoding genes. K. aerogenes and E. cloacae isolates (3 each) overexpressed AmpC. OmpC/K36 was disrupted in 20 isolates and OmpF/K35 was disrupted in 8 isolates.Among 357  CRE isolates identified during 6 years of surveillance, 48 (13.4% of the CRE) isolates did not produce known carbapenemases. The CN-CRE collection included 7 bacterial, species, or species complex. The top four most common species in the collection were MVB displayed good activity against CN-CRE isolates from US hospitals. This combination agent could be a good option to treat infections caused by these isolates.Mariana Castanheira, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Bravos Biosciences (Research Grant or Support)Cidara Therapeutics, Inc. (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)GlaxoSmithKline (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Qpex Biopharma (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Mariana Castanheira, PhD, Affinity Biosensors  Involved: Self): Research Grant or Support; Allergan  Involved: Self): Research Grant or Support; Amicrobe, Inc  Involved: Self): Research Grant or Support; Amplyx Pharma  Involved: Self): Research Grant or Support; Artugen Therapeutics USA, Inc.  Involved: Self): Research Grant or Support; Astellas  Involved: Self): Research Grant or Support; Basilea  Involved: Self): Research Grant or Support; Beth Israel Deaconess Medical Center  Involved: Self): Research Grant or Support; BIDMC  Involved: Self): Research Grant or Support; bioMerieux Inc.  Involved: Self): Research Grant or Support; BioVersys Ag  Involved: Self): Research Grant or Support; Bugworks  Involved: Self): Research Grant or Support; Cidara  Involved: Self): Research Grant or Support; Cipla  Involved: Self): Research Grant or Support; Contrafect  Involved: Self): Research Grant or Support; Cormedix  Involved: Self): Research Grant or Support; Crestone, Inc.  Involved: Self): Research Grant or Support; Curza  Involved: Self): Research Grant or Support; CXC7  Involved: Self): Research Grant or Support; Entasis  Involved: Self): Research Grant or Support; Fedora Pharmaceutical  Involved: Self): Research Grant or Support; Fimbrion Therapeutics  Involved: Self): Research Grant or Support; Fox Chase  Involved: Self): Research Grant or Support; GlaxoSmithKline  Involved: Self): Research Grant or Support; Guardian Therapeutics  Involved: Self): Research Grant or Support; Hardy Diagnostics  Involved: Self): Research Grant or Support; IHMA  Involved: Self): Research Grant or Support; Janssen Research & Development  Involved: Self): Research Grant or Support; Johnson & Johnson  Involved: Self): Research Grant or Support; Kaleido Biosceinces  Involved: Self): Research Grant or Support; KBP Biosciences  Involved: Self): Research Grant or Support; Luminex  Involved: Self): Research Grant or Support; Matrivax  Involved: Self): Research Grant or Support; Mayo Clinic  Involved: Self): Research Grant or Support; Medpace  Involved: Self): Research Grant or Support; Meiji Seika Pharma Co., Ltd.  Involved: Self): Research Grant or Support; Melinta  Involved: Self): Research Grant or Support; Menarini  Involved: Self): Research Grant or Support; Merck  Involved: Self): Research Grant or Support; Meridian Bioscience Inc.  Involved: Self): Research Grant or Support; Micromyx  Involved: Self): Research Grant or Support; MicuRx  Involved: Self): Research Grant or Support; N8 Medical  Involved: Self): Research Grant or Support; Nabriva  Involved: Self): Research Grant or Support; National Institutes of Health  Involved: Self): Research Grant or Support; National University of Singapore  Involved: Self): Research Grant or Support; North Bristol NHS Trust  Involved: Self): Research Grant or Support; Novome Biotechnologies  Involved: Self): Research Grant or Support; Paratek  Involved: Self): Research Grant or Support; Pfizer  Involved: Self): Research Grant or Support; Prokaryotics Inc.  Involved: Self): Research Grant or Support; QPEX Biopharma  Involved: Self): Research Grant or Support; Rhode Island Hospital  Involved: Self): Research Grant or Support; RIHML  Involved: Self): Research Grant or Support; Roche  Involved: Self): Research Grant or Support; Roivant  Involved: Self): Research Grant or Support; Salvat  Involved: Self): Research Grant or Support; Scynexis  Involved: Self): Research Grant or Support; SeLux Diagnostics  Involved: Self): Research Grant or Support; Shionogi  Involved: Self): Research Grant or Support; Specific Diagnostics  Involved: Self): Research Grant or Support; Spero  Involved: Self): Research Grant or Support; SuperTrans Medical LT  Involved: Self): Research Grant or Support; T2 Biosystems  Involved: Self): Research Grant or Support; The University of Queensland  Involved: Self): Research Grant or Support; Thermo Fisher Scientific  Involved: Self): Research Grant or Support; Tufts Medical Center  Involved: Self): Research Grant or Support; Universite de Sherbrooke  Involved: Self): Research Grant or Support; University of Iowa  Involved: Self): Research Grant or Support; University of Iowa Hospitals and Clinics  Involved: Self): Research Grant or Support; University of Wisconsin  Involved: Self): Research Grant or Support; UNT System College of Pharmacy  Involved: Self): Research Grant or Support; URMC  Involved: Self): Research Grant or Support; UT Southwestern  Involved: Self): Research Grant or Support; VenatoRx  Involved: Self): Research Grant or Support; Viosera Therapeutics  Involved: Self): Research Grant or Support; Wayne State University  Involved: Self): Research Grant or Support Timothy B. Doyle, AbbVie (formerly Allergan) (Research Grant or Support)Bravos Biosciences (Research Grant or Support)GlaxoSmithKline (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Valerie Kantro, n/a, Melinta Therapeutics, Inc. (Research Grant or Support) Rodrigo E. Mendes, PhD, AbbVie (Research Grant or Support)AbbVie (formerly Allergan) (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)ContraFect Corporation (Research Grant or Support)GlaxoSmithKline, LLC (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Nabriva Therapeutics (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Dee Shortridge, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Shionogi (Research Grant or Support)


This article has been corrected: The authors have found a typing mistake in the FUNDING section: Zhejiang Provincial Natural Science Foundation (No.Y19H270018) should be (No.LY19H270004). The correct section is presented below.Zhejiang Provincial Natural Science Foundation . Special project for the modernization of traditional Chinese medicine in Zhejiang Province (No. 2020ZX007). National TCM clinical research base construction project (No. 2015H0105). National Natural Science Foundation of China (No. 81800138).


Scientific Reports 10.1038/s41598-021-01185-7, published online 05 November 2021Correction to: The Acknowledgments section in the original version of this Article was incomplete.“This study was funded by core research grant from National Institute of Plant Genome Research. MI acknowledges CSIR, India for Senior Research Associateship (CSIR Pool Number: 8862-A).”now reads:“This study was funded both by core research grant from National Institute of Plant Genome Research and Department of Biotechnology, Ministry of Science and Technology, Government of India. MI acknowledges CSIR, India for Senior Research Associateship (CSIR Pool Number: 8862-A).”The original Article has been corrected.


Scientific Reports 10.1038/s41598-019-47651-1, published online 05 August 2019Correction to: The Acknowledgements section in the original version of this Article was incomplete.“This work was based on work supported by the National Science Foundation through Grant CHE 1607949 (TGIII).”now reads:“This work was based on work supported by the National Science Foundation through Grant CHE 1607949 (TGIII). This material is based upon work supported by the Air Force Office of Scientific Research under award number FA9550-17-1-0457."The original Article has been corrected.


In the original publication  there waIncorrect fundingThis research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number HI20C1496), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889).Correct fundingThis research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea , the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889).


Staphylococcus aureus (SA) bacteremia (SAB), including right-sided infective endocarditis (IE), used in addition to standard-of-care antibiotics. CF-301 in vitro activity was determined against SA isolates reflecting the Phase 3 target patient SAB population, including IE.Exebacase (CF-301) is a lysin (peptidoglycan hydrolase enzyme) with anti-staphylococcal activity. CF-301 is in Phase 3 of clinical development for the treatment of 666 SA recovered from blood (3% from known IE) of patients hospitalized in 29 centers located in 9 Census regions were included as part of the SENTRY Antimicrobial Surveillance Program for 2020. Identification was confirmed by MALDI-TOF. Susceptibility to 12 comparators used reference broth microdilution (BMD), whereas CF-301 used a modified BMD method with cation-adjusted Mueller-Hinton broth (CAMHB) supplemented with 25% horse serum and 0.5 mM DL-dithiothreitol according to CLSI. MIC interpretation for comparator agents used CLSI criteria, including determination of multidrug-resistant (MDR) phenotype (non-susceptible to ≥3 classes of antibiotics).50, MIC90 and modal MIC values of 0.5 mg/L. CF-301 MIC results  against methicillin-susceptible (MSSA) and -resistant  SA were identical. Many comparators had activity against MSSA; among drugs indicated for treating SAB caused by MRSA, daptomycin and vancomycin were active (100% susceptible) against all isolates. A total of 62.3% of MRSA isolates were categorized as MDR, and CF-301 showed equal MIC50 and MIC90 results against MDR  and non-MDR  populations. Daptomycin and vancomycin were active (100% susceptible) against MDR MRSA isolates.Against all SA tested CF-301 had an MIC range of 0.06-1 mg/L, with MICCF-301 was uniformly active against contemporary SA isolates responsible for bloodstream infections in the US in 2020. CF-301 activity was consistent, regardless of resistance phenotype . Surveillance data presented here further support the clinical development of CF-301 as a promising option for treatment of SAB, including those caused by MDR MRSA isolates.Rodrigo E. Mendes, PhD, AbbVie (Research Grant or Support)AbbVie (formerly Allergan) (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)ContraFect Corporation (Research Grant or Support)GlaxoSmithKline, LLC (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Nabriva Therapeutics (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Jill Lindley, Bravos Biosciences (Research Grant or Support)ContraFect Corporation (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Qpex Biopharma (Research Grant or Support) Nabina Gurung, n/a, ContraFect Corporation (Research Grant or Support) Mariana Castanheira, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Bravos Biosciences (Research Grant or Support)Cidara Therapeutics, Inc. (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)GlaxoSmithKline (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Qpex Biopharma (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Mariana Castanheira, PhD, Affinity Biosensors  Involved: Self): Research Grant or Support; Allergan  Involved: Self): Research Grant or Support; Amicrobe, Inc  Involved: Self): Research Grant or Support; Amplyx Pharma  Involved: Self): Research Grant or Support; Artugen Therapeutics USA, Inc.  Involved: Self): Research Grant or Support; Astellas  Involved: Self): Research Grant or Support; Basilea  Involved: Self): Research Grant or Support; Beth Israel Deaconess Medical Center  Involved: Self): Research Grant or Support; BIDMC  Involved: Self): Research Grant or Support; bioMerieux Inc.  Involved: Self): Research Grant or Support; BioVersys Ag  Involved: Self): Research Grant or Support; Bugworks  Involved: Self): Research Grant or Support; Cidara  Involved: Self): Research Grant or Support; Cipla  Involved: Self): Research Grant or Support; Contrafect  Involved: Self): Research Grant or Support; Cormedix  Involved: Self): Research Grant or Support; Crestone, Inc.  Involved: Self): Research Grant or Support; Curza  Involved: Self): Research Grant or Support; CXC7  Involved: Self): Research Grant or Support; Entasis  Involved: Self): Research Grant or Support; Fedora Pharmaceutical  Involved: Self): Research Grant or Support; Fimbrion Therapeutics  Involved: Self): Research Grant or Support; Fox Chase  Involved: Self): Research Grant or Support; GlaxoSmithKline  Involved: Self): Research Grant or Support; Guardian Therapeutics  Involved: Self): Research Grant or Support; Hardy Diagnostics  Involved: Self): Research Grant or Support; IHMA  Involved: Self): Research Grant or Support; Janssen Research & Development  Involved: Self): Research Grant or Support; Johnson & Johnson  Involved: Self): Research Grant or Support; Kaleido Biosceinces  Involved: Self): Research Grant or Support; KBP Biosciences  Involved: Self): Research Grant or Support; Luminex  Involved: Self): Research Grant or Support; Matrivax  Involved: Self): Research Grant or Support; Mayo Clinic  Involved: Self): Research Grant or Support; Medpace  Involved: Self): Research Grant or Support; Meiji Seika Pharma Co., Ltd.  Involved: Self): Research Grant or Support; Melinta  Involved: Self): Research Grant or Support; Menarini  Involved: Self): Research Grant or Support; Merck  Involved: Self): Research Grant or Support; Meridian Bioscience Inc.  Involved: Self): Research Grant or Support; Micromyx  Involved: Self): Research Grant or Support; MicuRx  Involved: Self): Research Grant or Support; N8 Medical  Involved: Self): Research Grant or Support; Nabriva  Involved: Self): Research Grant or Support; National Institutes of Health  Involved: Self): Research Grant or Support; National University of Singapore  Involved: Self): Research Grant or Support; North Bristol NHS Trust  Involved: Self): Research Grant or Support; Novome Biotechnologies  Involved: Self): Research Grant or Support; Paratek  Involved: Self): Research Grant or Support; Pfizer  Involved: Self): Research Grant or Support; Prokaryotics Inc.  Involved: Self): Research Grant or Support; QPEX Biopharma  Involved: Self): Research Grant or Support; Rhode Island Hospital  Involved: Self): Research Grant or Support; RIHML  Involved: Self): Research Grant or Support; Roche  Involved: Self): Research Grant or Support; Roivant  Involved: Self): Research Grant or Support; Salvat  Involved: Self): Research Grant or Support; Scynexis  Involved: Self): Research Grant or Support; SeLux Diagnostics  Involved: Self): Research Grant or Support; Shionogi  Involved: Self): Research Grant or Support; Specific Diagnostics  Involved: Self): Research Grant or Support; Spero  Involved: Self): Research Grant or Support; SuperTrans Medical LT  Involved: Self): Research Grant or Support; T2 Biosystems  Involved: Self): Research Grant or Support; The University of Queensland  Involved: Self): Research Grant or Support; Thermo Fisher Scientific  Involved: Self): Research Grant or Support; Tufts Medical Center  Involved: Self): Research Grant or Support; Universite de Sherbrooke  Involved: Self): Research Grant or Support; University of Iowa  Involved: Self): Research Grant or Support; University of Iowa Hospitals and Clinics  Involved: Self): Research Grant or Support; University of Wisconsin  Involved: Self): Research Grant or Support; UNT System College of Pharmacy  Involved: Self): Research Grant or Support; URMC  Involved: Self): Research Grant or Support; UT Southwestern  Involved: Self): Research Grant or Support; VenatoRx  Involved: Self): Research Grant or Support; Viosera Therapeutics  Involved: Self): Research Grant or Support; Wayne State University  Involved: Self): Research Grant or Support Ray Schuch, PhD, ContraFect Corporation (Employee) Jane E. Ambler, PhD, ContraFect Corporation (Employee)


The section should read: ``German Federal Ministry of Research and Education (01ZZ1802); Physician-Scientist Program of the University of Heidelberg, Faculty of Medicine, DKTK (German Cancer Consortium) School of Oncology and the Cancer Core Europe TRYTRAC program (to A.M.); MTB-Report project (VolkswagenStiftung ZN3424) (to J.H.).'' instead of ``German Federal Ministry of Research and Education (01ZZ1802); University of Heidelberg, Faculty of Medicine (to A.M.); Volkswagen Foundation (to J.H.).'' This has now been corrected.


Correction to:Health Justice9, 27 (2021).https://doi.org/10.1186/s40352-021-00150-wThere are multiple, repeated references for ‘United Nations Office on Drugs and Crime’ in the reference list.(2 instances) United Nations Office on Drugs and Crime (UNODC). (2015). The United Nations Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules). Retrieved from https://www.unodc.org/documents/justice-and-prison- reform/Nelson_Mandela_Rules-E-ebook.pdf(2 instances) United Nations Office on Drugs and Crime (UNODC). (2020). COVID-19 prevention and control among people working in prisonThese include:In the reference list, ‘Retrieved from’ still remains in many instances where there is no URL; we had asked for these to be removed prior to publication.Supplementary appendix Following the publication of the original article (Pearce et al., The original article (Pearce et al., Additional file 1: Appendix S1. List of recommendations by domain and sub-domain.


Scientific Reports 10.1038/s41598-021-86146-w, published online 23 March 2021Correction to: The original version of this Article contained an error in the Acknowledgments section. “This research was supported by the following grants: National Natural Science Foundation of China (NSFC) No. 81671909 and 8190195, Zhejiang Provincial Natural Science Foundation of China under Grants No. LY18H150004, LY19H150004 and LY20H150010, and Key Research and Development Project of Sichuan Science and Technology Department No. 2018SZ0380.”now reads:“This research was supported by the following grants: National Natural Science Foundation of China (NSFC) No. 81671909 and 81901958, Zhejiang Provincial Natural Science Foundation of China under Grants No. LY18H150004, LY19H150004 and LY20H150010, and Key Research and Development Project of Sichuan Science and Technology Department No. 2018SZ0380.”The original Article has been corrected.


Page 15: The following should be added to Acknowledgments after paragraph 2.Volume 95, no. 17, e01868-20, 2021, This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences, National Institutes of Health (grant P30 GM124165). The Eiger 16M detector on the 24-ID-E beamline is funded by an NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by the Argonne National Laboratory under contract no. DE-AC02-06CH11357.


Scientific Reports 10.1038/s41598-021-98627-z, published online 29 September 2021Correction to: The Acknowledgements section in the original version of this Article was incomplete.“The authors thank Kezhong Zhang of Wayne State University for providing the anti-CREB3L3 antibody. The work was supported by R00 DK090210, R01 DK109015, University of Chicago DRTC (DK020595) Pilot & Feasibility award, Central for Society for Clinical and Translational Research Early Career Development Award and UIC Startup fund (C.W.L.); M.A.M. was supported by an American Heart Association Predoctoral Fellowship (Grant No. 16PRE30190011). M.B. was funded by the Deutsche Forschungsgemeinschaft: Collaborative Research Center SFB1052, project B1.”now reads:“The authors thank Kezhong Zhang of Wayne State University for providing the anti-CREB3L3 antibody. The authors also acknowledge the Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article. The work was supported by R00 DK090210, R01 DK109015, University of Chicago DRTC (DK020595) Pilot & Feasibility award, Central for Society for Clinical and Translational Research Early Career Development Award and UIC Startup fund (C.W.L.); M.A.M. was supported by an American Heart Association Predoctoral Fellowship. M.B. was funded by the Deutsche Forschungsgemeinschaft: Collaborative Research Center SFB1052, project B1.”The original Article has been corrected.


We evaluated the BSI results in 2018-2020.The IDEA Program monitors the 8,643 organisms were consecutively collected (1/patient) from 74 medical centers located in the US , western EU , and eastern EU . Organisms were susceptibility tested by reference broth microdilution methods in a central laboratory. S. aureus , E. faecalis , S. epidermidis , β-hemolytic streptococci , and E. faecium , but rank order varied markedly by geographic region. The top 3 GP organisms were SA, EF, and BHS in the US; SA, EF, and EFM in W-EU; and SA, S. pneumoniae, and BHS in E-EU. Dalbavancin was highly active against methicillin-susceptible (MSSA) and -resistant (MRSA) SA, with an MIC90 of 0.03 mg/L in all 3 regions (Table). Among SA, MRSA rates were higher in the US (41.3%) than W-EU (21.5%) or E-EU (27.3%), and ceftaroline susceptibility ranged from 95.4% (W-EU) to 96.6% (US). Vancomycin (VAN) susceptibility varied from 97.3% (E-EU) to 98.3% (W-EU) among EF (97.5% in US), and dalbavancin was active against all VAN-S EF . Among SEP, all isolates were inhibited at ≤0.25 mg/L of dalbavancin  and oxacillin resistance ranged from 66.9% in W-EU to 86.5% in E-EU (73.2% in US). BHS exhibited low dalbavancin MIC values  and high S rates for its comparators. Among EFM, VAN-S rates varied from 36.6% in the US to 61.6% in E-EU and 76.1% in W-EU, and dalbavancin inhibited all VAN-S EFM at ≤0.25 mg/L .Overall, the most common GP organisms were Dalbavancin exhibited potent activity and broad spectrum against a large collection of contemporary GP bacteria recovered from patients with BSI in US and EU. Helio S. Sader, MD, PhD, FIDSA, AbbVie (formerly Allergan) (Research Grant or Support)Basilea Pharmaceutica International, Ltd. (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)Department of Health and Human Services Melinta Therapeutics, LLC (Research Grant or Support)Nabriva Therapeutics (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Mariana Castanheira, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Bravos Biosciences (Research Grant or Support)Cidara Therapeutics, Inc. (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)GlaxoSmithKline (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Qpex Biopharma (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support) Mariana Castanheira, PhD, Affinity Biosensors  Involved: Self): Research Grant or Support; Allergan  Involved: Self): Research Grant or Support; Amicrobe, Inc  Involved: Self): Research Grant or Support; Amplyx Pharma  Involved: Self): Research Grant or Support; Artugen Therapeutics USA, Inc.  Involved: Self): Research Grant or Support; Astellas  Involved: Self): Research Grant or Support; Basilea  Involved: Self): Research Grant or Support; Beth Israel Deaconess Medical Center  Involved: Self): Research Grant or Support; BIDMC  Involved: Self): Research Grant or Support; bioMerieux Inc.  Involved: Self): Research Grant or Support; BioVersys Ag  Involved: Self): Research Grant or Support; Bugworks  Involved: Self): Research Grant or Support; Cidara  Involved: Self): Research Grant or Support; Cipla  Involved: Self): Research Grant or Support; Contrafect  Involved: Self): Research Grant or Support; Cormedix  Involved: Self): Research Grant or Support; Crestone, Inc.  Involved: Self): Research Grant or Support; Curza  Involved: Self): Research Grant or Support; CXC7  Involved: Self): Research Grant or Support; Entasis  Involved: Self): Research Grant or Support; Fedora Pharmaceutical  Involved: Self): Research Grant or Support; Fimbrion Therapeutics  Involved: Self): Research Grant or Support; Fox Chase  Involved: Self): Research Grant or Support; GlaxoSmithKline  Involved: Self): Research Grant or Support; Guardian Therapeutics  Involved: Self): Research Grant or Support; Hardy Diagnostics  Involved: Self): Research Grant or Support; IHMA  Involved: Self): Research Grant or Support; Janssen Research & Development  Involved: Self): Research Grant or Support; Johnson & Johnson  Involved: Self): Research Grant or Support; Kaleido Biosceinces  Involved: Self): Research Grant or Support; KBP Biosciences  Involved: Self): Research Grant or Support; Luminex  Involved: Self): Research Grant or Support; Matrivax  Involved: Self): Research Grant or Support; Mayo Clinic  Involved: Self): Research Grant or Support; Medpace  Involved: Self): Research Grant or Support; Meiji Seika Pharma Co., Ltd.  Involved: Self): Research Grant or Support; Melinta  Involved: Self): Research Grant or Support; Menarini  Involved: Self): Research Grant or Support; Merck  Involved: Self): Research Grant or Support; Meridian Bioscience Inc.  Involved: Self): Research Grant or Support; Micromyx  Involved: Self): Research Grant or Support; MicuRx  Involved: Self): Research Grant or Support; N8 Medical  Involved: Self): Research Grant or Support; Nabriva  Involved: Self): Research Grant or Support; National Institutes of Health  Involved: Self): Research Grant or Support; National University of Singapore  Involved: Self): Research Grant or Support; North Bristol NHS Trust  Involved: Self): Research Grant or Support; Novome Biotechnologies  Involved: Self): Research Grant or Support; Paratek  Involved: Self): Research Grant or Support; Pfizer  Involved: Self): Research Grant or Support; Prokaryotics Inc.  Involved: Self): Research Grant or Support; QPEX Biopharma  Involved: Self): Research Grant or Support; Rhode Island Hospital  Involved: Self): Research Grant or Support; RIHML  Involved: Self): Research Grant or Support; Roche  Involved: Self): Research Grant or Support; Roivant  Involved: Self): Research Grant or Support; Salvat  Involved: Self): Research Grant or Support; Scynexis  Involved: Self): Research Grant or Support; SeLux Diagnostics  Involved: Self): Research Grant or Support; Shionogi  Involved: Self): Research Grant or Support; Specific Diagnostics  Involved: Self): Research Grant or Support; Spero  Involved: Self): Research Grant or Support; SuperTrans Medical LT  Involved: Self): Research Grant or Support; T2 Biosystems  Involved: Self): Research Grant or Support; The University of Queensland  Involved: Self): Research Grant or Support; Thermo Fisher Scientific  Involved: Self): Research Grant or Support; Tufts Medical Center  Involved: Self): Research Grant or Support; Universite de Sherbrooke  Involved: Self): Research Grant or Support; University of Iowa  Involved: Self): Research Grant or Support; University of Iowa Hospitals and Clinics  Involved: Self): Research Grant or Support; University of Wisconsin  Involved: Self): Research Grant or Support; UNT System College of Pharmacy  Involved: Self): Research Grant or Support; URMC  Involved: Self): Research Grant or Support; UT Southwestern  Involved: Self): Research Grant or Support; VenatoRx  Involved: Self): Research Grant or Support; Viosera Therapeutics  Involved: Self): Research Grant or Support; Wayne State University  Involved: Self): Research Grant or Support Michael D. Huband, BS, AbbVie (formerly Allergan) (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support) Dee Shortridge, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Shionogi (Research Grant or Support) Cecilia G. Carvalhaes, MD, PhD, AbbVie (formerly Allergan) (Research Grant or Support)Cidara Therapeutics, Inc. (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Pfizer, Inc. (Research Grant or Support) Rodrigo E. Mendes, PhD, AbbVie (Research Grant or Support)AbbVie (formerly Allergan) (Research Grant or Support)Cipla Therapeutics (Research Grant or Support)Cipla USA Inc. (Research Grant or Support)ContraFect Corporation (Research Grant or Support)GlaxoSmithKline, LLC (Research Grant or Support)Melinta Therapeutics, Inc. (Research Grant or Support)Melinta Therapeutics, LLC (Research Grant or Support)Nabriva Therapeutics (Research Grant or Support)Pfizer, Inc. (Research Grant or Support)Shionogi (Research Grant or Support)Spero Therapeutics (Research Grant or Support)


Scientific Reports 10.1038/s41598-021-86985-7, published online 05 April 2020Correction to: The original version of this Article contained an error in the Funding section.“Open access funding provided by Uppsala University. This research was funded by the Knut and Alice Wallenberg Foundation (WAF 2016.0112) and the European Research Council (ERC-2017-STG-757444).”now reads:“Open access funding has been provided by Uppsala University. This research has received funding from the Knut and Alice Wallenberg Foundation (WAF 2016.0112), the Swedish Research Council (2019-03797) and from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 757444).”The original Article has been corrected.


The STAR-VA program was an initiative out of what is now called the VA Office of Mental Health and Suicide Prevention, partnering with the national Offices of Geriatrics and Extended Care and Nursing Services. Ongoing collaboration with these national, as well as regional and medical-center-level leaders, has been critical for informing program implementation and dissemination strategies. We will discuss several key partnered strategies, including (1) linking STAR-VA to national CLC systematic quality improvement efforts; (2) engaging national inter-office program leaders in decisions about outreach to and inclusion of facilities in STAR-VA training and implementation; (3) training local STAR-VA champions on strategies for engaging local leadership support; (4) briefing leaders across the system with program updates; and (5) using national VA data to inform STAR-VA sustained implementation. Discussion will address challenges and opportunities for engaging leadership stakeholders in facilitating sustained implementation of evidence-based programs.


Scientific Reports 10.1038/s41598-017-04641-5, published online 08 September 2017Correction to: The original version of this Article contained an error in Figure 1, where the unit for the y-axis of panel (c) was incorrect. The original Figure In addition, in the Acknowledgements section, the grant numbers for Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholar were incorrect.“This work was supported by the National Natural Science Foundation of China , Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholar (No. R17F040007), Ningbo Municipal Natural Science Foundation (No. 2014A610011), the Ningbo Natural Science Foundation of China , the State Key Basic Research Program of China (2013CB922300), Youth Innovation Promotion Association, Chinese Academy of Sciences and Royal Academy of Engineering, UK. The author appreciates the K.C. Wong Magna Fund in Ningbo University.”now reads:“This work was supported by the Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholar (No. LR17F040002), National Natural Science Foundation of China , Ningbo Municipal Natural Science Foundation (No. 2014A610011), the Ningbo Natural Science Foundation of China , the State Key Basic Research Program of China (2013CB922300), Youth Innovation Promotion Association, Chinese Academy of Sciences and Royal Academy of Engineering, UK. The author appreciates the K.C. Wong Magna Fund in Ningbo University.”The original Article has been corrected.